-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A New Treatment Option for Patients with Acute Myeloid Leukemia

Program: Product Theaters
Session: A New Treatment Option for Patients with Acute Myeloid Leukemia
Saturday, December 5, 2020, 11:00 AM-12:00 PM

Michelle Little, PhD

Bristol Myers Squibb, Princeton, NJ

Disclosures: No relevant conflicts of interest to declare.

See more of: A New Treatment Option for Patients with Acute Myeloid Leukemia
See more of: Product Theaters